Total Payments
$20,207
2024 Payments
$2,585
Companies
59
Transactions
1,413
Medicare Patients
6,509
Medicare Billing
$506,802
Payment Breakdown by Category
Food & Beverage$19,921 (98.6%)
Education$285.98 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,921 | 1,399 | 98.6% |
| Education | $285.98 | 14 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $2,057 | 161 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,888 | 80 | $0 (2024) |
| Lilly USA, LLC | $1,715 | 132 | $0 (2024) |
| Novo Nordisk Inc | $1,700 | 110 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,335 | 122 | $0 (2024) |
| ABBVIE INC. | $1,295 | 91 | $0 (2024) |
| Amgen Inc. | $1,093 | 62 | $0 (2024) |
| Astellas Pharma US Inc | $790.37 | 43 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $719.17 | 39 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $702.87 | 34 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,585 | 135 | Novo Nordisk Inc ($338.60) |
| 2023 | $2,778 | 160 | PFIZER INC. ($405.75) |
| 2022 | $2,702 | 192 | ABBVIE INC. ($298.09) |
| 2021 | $2,739 | 196 | AbbVie Inc. ($321.97) |
| 2020 | $1,573 | 104 | Novo Nordisk Inc ($254.50) |
| 2019 | $2,412 | 177 | AstraZeneca Pharmaceuticals LP ($338.99) |
| 2018 | $2,795 | 224 | AstraZeneca Pharmaceuticals LP ($288.23) |
| 2017 | $2,623 | 225 | PFIZER INC. ($420.14) |
All Payment Transactions
1,413 individual payment records from CMS Open Payments — Page 1 of 57
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Neuroscience | ||||||
| 12/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/08/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $27.09 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Gastroenterology | ||||||
| 12/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Gastroenterology | ||||||
| 12/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Cardio-renal | ||||||
| 11/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $6.07 | General |
| Category: Diabetes | ||||||
| 11/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Cardio-renal | ||||||
| 11/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: Obesity | ||||||
| 11/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.05 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,288 | 2,097 | $311,280 | $114,338 |
| 2022 | 24 | 1,344 | 2,284 | $321,962 | $110,319 |
| 2021 | 22 | 1,724 | 2,920 | $382,190 | $136,448 |
| 2020 | 27 | 2,153 | 3,341 | $388,963 | $145,697 |
Total Patients
6,509
Total Services
10,642
Medicare Billing
$506,802
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 381 | 665 | $161,595 | $45,493 | 28.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 124 | 124 | $30,752 | $14,807 | 48.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 44 | 44 | $23,320 | $12,433 | 53.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 34 | 91 | $17,836 | $7,831 | 43.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 98 | 98 | $13,034 | $7,402 | 56.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 70 | $12,040 | $3,988 | 33.1% |
| 77085 | Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | Office | 2023 | 84 | 84 | $7,842 | $3,814 | 48.6% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 20 | 76 | $9,880 | $3,415 | 34.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 108 | 109 | $4,905 | $3,117 | 63.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 36 | 43 | $5,891 | $2,564 | 43.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 58 | 176 | $4,752 | $1,620 | 34.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $4,403 | $1,590 | 36.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 55 | 55 | $2,475 | $1,573 | 63.6% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 12 | 12 | $3,204 | $1,570 | 49.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 20 | 21 | $2,646 | $973.84 | 36.8% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 13 | 13 | $3,315 | $921.19 | 27.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 19 | 125 | $1,625 | $596.83 | 36.7% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 13 | 41 | $492.00 | $231.86 | 47.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 20 | 20 | $540.00 | $189.72 | 35.1% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 18 | 104 | $416.00 | $103.50 | 24.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 28 | 33 | $165.00 | $72.60 | 44.0% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 18 | 76 | $152.00 | $32.42 | 21.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 422 | 734 | $178,299 | $49,440 | 27.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 121 | 121 | $29,994 | $14,803 | 49.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 45 | 146 | $28,616 | $11,120 | 38.9% |
About Dr. Nancy Morris, M.D
Dr. Nancy Morris, M.D is a Internal Medicine healthcare provider based in London, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770543175.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nancy Morris, M.D has received a total of $20,207 in payments from pharmaceutical and medical device companies, with $2,585 received in 2024. These payments were reported across 1,413 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($19,921).
As a Medicare-enrolled provider, Morris has provided services to 6,509 Medicare beneficiaries, totaling 10,642 services with total Medicare billing of $506,802. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location London, KY
- Active Since 03/28/2006
- Last Updated 06/17/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1770543175
Products in Payments
- FARXIGA (Drug) $1,238
- JARDIANCE (Drug) $859.10
- ELIQUIS (Drug) $763.66
- TRULICITY (Drug) $756.79
- Kerendia (Drug) $702.87
- Livalo (Drug) $628.88
- Aimovig (Biological) $563.40
- NURTEC ODT (Drug) $548.55
- Ozempic (Drug) $548.37
- ENTRESTO (Drug) $514.96
- Saxenda (Drug) $473.15
- VRAYLAR (Drug) $460.58
- MYRBETRIQ (Drug) $453.44
- UBRELVY (Drug) $445.22
- CHANTIX (Drug) $434.01
- XIFAXAN (Drug) $414.19
- LINZESS (Drug) $382.31
- Vascepa (Drug) $379.73
- MOUNJARO (Drug) $349.85
- TOUJEO (Drug) $329.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in London
Mark Adams, M.d, M.D
Internal Medicine — Payments: $195,977
Internal Medicine $195,977
Dr. Michel Bidros, M.d, M.D
Internal Medicine — Payments: $8,854
Internal Medicine $8,854
Bryon Cook, M.d, M.D
Internal Medicine — Payments: $4,396
Internal Medicine $4,396
Kamran Mahmood, Md, MD
Internal Medicine — Payments: $3,304
Internal Medicine $3,304
Syed Mustafa, Md, Mbbs, MD, MBBS
Internal Medicine — Payments: $2,734
Internal Medicine $2,734
Dr. Emily White, M.d, M.D
Internal Medicine — Payments: $1,579
Internal Medicine $1,579